Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $277.6 million.

  • Cellebrite DI's Current Deferred Revenue rose 2793.61% to $277.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $277.6 million, marking a year-over-year increase of 2793.61%. This contributed to the annual value of $277.6 million for FY2025, which is 2793.61% up from last year.
  • As of Q4 2025, Cellebrite DI's Current Deferred Revenue stood at $277.6 million, which was up 2793.61% from $239.7 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Current Deferred Revenue registered a high of $277.6 million during Q4 2025, and its lowest value of $115.0 million during Q3 2021.
  • Over the past 5 years, Cellebrite DI's median Current Deferred Revenue value was $185.0 million (recorded in 2024), while the average stood at $185.1 million.
  • As far as peak fluctuations go, Cellebrite DI's Current Deferred Revenue skyrocketed by 3406.04% in 2023, and later crashed by 1064.68% in 2024.
  • Over the past 5 years, Cellebrite DI's Current Deferred Revenue (Quarter) stood at $159.4 million in 2021, then grew by 22.25% to $194.9 million in 2022, then rose by 24.6% to $242.8 million in 2023, then dropped by 10.65% to $217.0 million in 2024, then increased by 27.94% to $277.6 million in 2025.
  • Its Current Deferred Revenue stands at $277.6 million for Q4 2025, versus $239.7 million for Q3 2025 and $227.2 million for Q2 2025.